Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Shaanxi Micot Pharmaceutical Technology Co., Ltd.

News headline image
Micot Pharma Showcases First-in-Class, Brain-Penetrant TrkB Agonist MT200605 at World Stroke Congress, Building the Case for Global Partnerships and Commercialization
From Shaanxi Micot Pharmaceutical Technology Co., Ltd.
Via ACN Newswire
News headline image
Micot Pharma Debuts MT200605 Huntington's Disease Research in a Poster Presentation at MDS 2026 and Expands Development into Neurodegenerative Diseases
From Shaanxi Micot Pharmaceutical Technology Co., Ltd.
Via ACN Newswire
News headline image
Micot's XTL6001 Featured in Two EASD Presentations: MasR/GCGR/GLP-1R Triple-Agonist Mechanism Opens a Differentiated Path Across Metabolic and Renal Disease
From Shaanxi Micot Pharmaceutical Technology Co., Ltd.
Via ACN Newswire
News headline image
Micot Pharma Reports Positive Operating Cash Flow and Advances Late-Stage Pipeline in 1H 2026
From Shaanxi Micot Pharmaceutical Technology Co., Ltd.
Via ACN Newswire
News headline image
Micot Pharma's MT200605 Achieves Primary Endpoint in Phase II Trial, Novel Integrated Multi-stage Neuroprotection Mechanism to Be Presented at WSC 2026
From Shaanxi Micot Pharmaceutical Technology Co., Ltd.
Via ACN Newswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.